IL-4 receptor blockade is a global repressor of naïve B cell development and responses in a dupilumab-treated patient is a research paper published in Clinical Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 20 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: AR-048311
National Institutes of Health
Grant: P30-AI-027767
National Institute of Allergy and Infectious Diseases
Grant: R01 AI134023
U.S. Department of Veterans Affairs
Grant: 1I01BX005448
U.S. Department of Veterans Affairs
Grant: I01BX004049
BLRD VA
Grant: I01 BX005448
NIAID NIH HHS
Grant: P30 AI027767
NIAMS NIH HHS
Grant: P30 AR048311
Lupus Research Alliance
FWCI
1.06
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals